Evaxion A (EVAX) Net Income Growth (1y) (2021 - 2026)
Evaxion A (EVAX) Net Income Growth (1y) (2021 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Net Income Growth (1y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Alterity Therapeutics | 925,601.88 Bn | 925,601.85 Bn | - | - |
| 2 | Belite Bio | 58,560.00 Bn | 58,560.00 Bn | - | -88.68% |
| 3 | Quantum Biopharma | 17,284.41 Bn | 17,284.40 Bn | - | 13.34% |
| 4 | Legend Biotech | 2,809.00 Bn | 2,808.71 Bn | 242.10 Mn | -43.69% |
| 5 | Evaxion A | 1,334.43 Bn | 1,334.42 Bn | - | -73.01% |
| 6 | Akari Therapeutics | 1,312.27 Bn | 1,312.26 Bn | - | -290.15% |
| 7 | Psyence Biomedical | 212.16 Bn | 212.16 Bn | - | -230.18% |
| 8 | Vertex Pharmaceuticals | 114.83 Bn | 107.58 Bn | 2.59 Bn | 59.59% |
| 9 | Abivax | 91.96 Bn | 91.96 Bn | - | - |
| 10 | Regeneron Pharmaceuticals | 63.43 Bn | 54.67 Bn | 3.31 Bn | -10.08% |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -73.01% |
| Dec 31, 2025 | 214.76% |
| Sep 30, 2025 | 562.91% |
| Jun 30, 2025 | 20.85% |
| Mar 31, 2025 | -359.10% |
| Dec 31, 2024 | 14.31% |
| Sep 30, 2024 | 64.94% |
| Jun 30, 2024 | -7.55% |
| Mar 31, 2024 | 111.43% |
| Dec 31, 2023 | 32.43% |
| Sep 30, 2023 | 0.39% |
| Jun 30, 2023 | -19.74% |
| Mar 31, 2023 | -5.47% |
| Dec 31, 2022 | -26.10% |
| Sep 30, 2022 | 0.16% |
| Jun 30, 2022 | 37.21% |
| Mar 31, 2022 | -28.08% |
| Dec 31, 2021 | -8.51% |
| Sep 30, 2021 | -18.08% |
| Jun 30, 2021 | -92.75% |